Search research articles
Contact Us
Filters
Showing results (1371-1380 of 1,779) with videos related to
Page
of 178
Sort By:
Mabs
|
April 1, 2025
Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning
Lateefat A Kalejaye, Jia-Min Chu, I-En Wu, et al.
Mabs
|
May 13, 2025
Structural and biochemical differences between non-catalytic and catalytic antibodies
Taizo Uda, Ryuichi Kato, Yasuteru Shigeta, et al.
Mabs
|
May 10, 2025
Biologics developability data analysis using hierarchical clustering accelerates candidate lead selection, optimization, and preformulation screening
Kevin James Metcalf, Galen Wo, Jan Paulo Zaragoza, et al.
Mabs
|
April 12, 2013
Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptides
David W LaFleur, Donara Abramyan, Palanisamy Kanakaraj, et al.
Mabs
|
April 12, 2013
High throughput solution-based measurement of antibody-antigen affinity and epitope binning
Patricia Estep, Felicia Reid, Claire Nauman, et al.
Mabs
|
March 16, 2013
8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland
Alain Beck, Paul J Carter, Hans-Peter Gerber, et al.
Mabs
|
December 11, 2012
Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
Michael Ritchie, Lioudmila Tchistiakova, Nathan Scott
Mabs
|
December 11, 2012
Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain
Caroline Mary, Flora Coulon, Nicolas Poirier, et al.
Mabs
|
December 11, 2012
Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use
Tanya Camacho-Villegas, Teresa Mata-Gonzalez, Jorge Paniagua-Solis, et al.
Mabs
|
December 21, 2012
Which are the antibodies to watch in 2013?
Janice M Reichert
Page
of 178
Search research articles
Search
Showing results (1371-1380 of 1,779) with videos related to
Sort By:
Page
of 178
Mabs
|
April 1, 2025
Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning
Lateefat A Kalejaye, Jia-Min Chu, I-En Wu, et al.
Mabs
|
May 13, 2025
Structural and biochemical differences between non-catalytic and catalytic antibodies
Taizo Uda, Ryuichi Kato, Yasuteru Shigeta, et al.
Mabs
|
May 10, 2025
Biologics developability data analysis using hierarchical clustering accelerates candidate lead selection, optimization, and preformulation screening
Kevin James Metcalf, Galen Wo, Jan Paulo Zaragoza, et al.
Mabs
|
April 12, 2013
Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptides
David W LaFleur, Donara Abramyan, Palanisamy Kanakaraj, et al.
Mabs
|
April 12, 2013
High throughput solution-based measurement of antibody-antigen affinity and epitope binning
Patricia Estep, Felicia Reid, Claire Nauman, et al.
Mabs
|
March 16, 2013
8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland
Alain Beck, Paul J Carter, Hans-Peter Gerber, et al.
Mabs
|
December 11, 2012
Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
Michael Ritchie, Lioudmila Tchistiakova, Nathan Scott
Mabs
|
December 11, 2012
Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain
Caroline Mary, Flora Coulon, Nicolas Poirier, et al.
Mabs
|
December 11, 2012
Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use
Tanya Camacho-Villegas, Teresa Mata-Gonzalez, Jorge Paniagua-Solis, et al.
Mabs
|
December 21, 2012
Which are the antibodies to watch in 2013?
Janice M Reichert
Page
of 178